Thomas Kean (House) serves on House Committee on Energy and Commerce, whose remit touches Health. An official disclosure shows a $1K–$15K sale of $SYK (Stryker Corp.), dated 2026-09-30.
We flag this as an overlap between a member's committee role and their disclosed trading — a question worth seeing in the open. It is not a claim that the trade was improper, informed by the committee, or mistimed; many such overlaps are entirely ordinary.
A financial disclosure is a public record filed under the STOCK Act, not evidence of wrongdoing. Amounts are reported as ranges, and any figures here are drawn from official filings. This is a transparency record, not investment advice.